bpc-157 original Peptide Therapy BPC-157: Experimental Peptide Creates Risk

Category 2 is the FDA's designation for bulk drug substances nominated for compounding consideration that have been identified as presenting potential safety risks and are currently ineligible for routine compounding under Section 503A

Combining ibuprofen with corticosteroids like prednisone can significantly increase the risk of stomach ulcers and bleeding

While additional studies are needed to determine whether elevated vitamin B 12 status may be related to cancer development, including evaluating whether it might be a potential marker of cancer, it is important for observational studies to adequately control for potential confounders, such as age, menopausal status, alcohol use, and intake of the B-vitamin folate

Some providers may discuss these peptides separately, while others may evaluate whether they fit into a broader recovery or wellness plan